Related Experiment Video
Updated: May 7, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis
Alessandra Musella1, Georgia Mandolesi, Antonietta Gentile
1Fondazione Santa Lucia, Centro Europeo per la Ricerca sul Cervello (CERC), 00143 Rome, Italy; UOC Neurologia, Dipartimento di Medicina dei Sistemi, Università Tor Vergata, 00133 Rome, Italy.
Abstract:
Alterations of glutamate-mediated synaptic transmission occur in both multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), the animal model of MS. Here we investigated whether intracerebroventricular (Icv) administration of cladribine has effects on EAE. Icv infusion of cladribine reduced the clinical deficits of EAE mice and reversed EAE-induced enhancement of excitatory postsynaptic current (sEPSC) frequency, a neurophysiological measure of glutamatergic synaptopathy associated with central inflammation. Cladribine failed to interfere with EAE-induced microglial and astroglial activation, but blocked EAE synaptic alterations by interfering with interleukin-1β effects. Cladribine possesses neuroprotective properties in experimental MS that are independent of its peripheral immunosuppressant action.
Insights
Cladribine, delivered intracerebroventricularly, reduced multiple sclerosis (MS) symptoms in mice by protecting against synaptic damage. This neuroprotection occurred independently of its immunosuppressive effects.
Area of Science:
- Neuroimmunology
- Neuropharmacology
- Neurophysiology
Background:
- Multiple sclerosis (MS) involves glutamate-mediated synaptic transmission alterations.
- Experimental autoimmune encephalomyelitis (EAE) models MS, exhibiting similar synaptic dysfunction.
- Central nervous system inflammation in EAE impacts glutamatergic synapses.
Purpose of the Study:
- To investigate the effects of intracerebroventricular (Icv) cladribine administration on EAE.
- To determine if cladribine offers neuroprotection in experimental MS.
- To elucidate the mechanism of cladribine's action on synaptic alterations in EAE.
Main Methods:
- Intracerebroventricular (Icv) infusion of cladribine in EAE mice.
- Assessment of clinical EAE scores.
- Electrophysiological recordings to measure excitatory postsynaptic current (sEPSC) frequency.
- Evaluation of microglial and astroglial activation.
- Analysis of interleukin-1β (IL-1β) involvement.
Main Results:
- Icv cladribine administration significantly reduced clinical deficits in EAE mice.
- Cladribine reversed the EAE-induced enhancement of sEPSC frequency, indicating protection against glutamatergic synaptopathy.
- Cladribine did not affect EAE-induced microglial or astroglial activation.
- Cladribine blocked EAE synaptic alterations by interfering with interleukin-1β effects.
Conclusions:
- Intracerebroventricular cladribine exhibits neuroprotective properties in experimental MS (EAE).
- Cladribine's neuroprotection in EAE is mediated by interfering with IL-1β effects on synaptic function.
- These neuroprotective effects are independent of cladribine's peripheral immunosuppressant actions.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inhibitors of Viral Protein Synthesis
Multiple Sclerosis l: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Intracellular Signaling Affects Focal Adhesions
Some...
